Author of the publication

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects

C. Boschi, D. Scheim, A. Bancod, M. Militello, M. Bideau, P. Colson, J. Fantini, and B. Scola. International Journal of Molecular Sciences, 23 (24): 15480 (December 2022)
DOI: 10.3390/ijms232415480

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Egmont Scola

Roland Scola

Alexander Scola

Wolfgang Scola

Other publications of authors with the same name

Correlation Between 3790 Quantitative Polymerase Chain Reaction–Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 IsolatesR. Jaafar, S. Aherfi, N. Wurtz, C. Grimaldier, T. Hoang, P. Colson, D. Raoult, and B. La Scola. Clinical Infectious Diseases, (2020)Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysisJ. Lagier, M. Million, P. Gautret, P. Colson, S. Cortaredona, A. Giraud-Gatineau, S. Honoré, J. Gaubert, P. Fournier, H. Tissot-Dupont and 33 other author(s). Travel Medicine and Infectious Disease, (2020)Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometryP. Seng, M. Drancourt, F. Gouriet, B. Scola, {. Fournier, J. Rolain, and D. Raoult. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 49 (4): 543--551 (August 2009)PMID: 19583519.Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, FranceM. Million, J. Lagier, P. Gautret, P. Colson, P. Fournier, S. Amrane, M. Hocquart, M. Mailhe, V. Esteves-Vieira, B. Doudier and 27 other author(s). Travel Medicine and Infectious Disease, (2020)Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wardsB. La Scola, M. Le Bideau, J. Andreani, V. Hoang, C. Grimaldier, P. Colson, P. Gautret, and D. Raoult. European Journal of Clinical Microbiology & Infectious Diseases, 39 (6): 1059--1061 (Jun 1, 2020)In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2M. Gendrot, J. Andreani, P. Jardot, S. Hutter, O. Delandre, M. Boxberger, J. Mosnier, M. Bideau, I. Duflot, I. Fonta and 4 other author(s). Molecules, 25 (21): 5064 (October 2020)Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, FranceM. Million, J. Lagier, P. Gautret, P. Colson, P. Fournier, S. Amrane, M. Hocquart, M. Mailhe, V. Esteves-Vieira, B. Doudier and 27 other author(s). Travel Medicine and Infectious Disease, (2020)Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational studyP. Gautret, J. Lagier, P. Parola, V. Hoang, L. Meddeb, J. Sevestre, M. Mailhe, B. Doudier, C. Aubry, S. Amrane and 19 other author(s). Travel Medicine and Infectious Disease, (2020)This is the second Marseille study.SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse EffectsC. Boschi, D. Scheim, A. Bancod, M. Millitello, M. Bideau, P. Colson, J. Fantini, and B. Scola. bioRxiv, (2022)Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialP. Gautret, J. Lagier, P. Parola, V. Hoang, L. Meddeb, M. Mailhe, B. Doudier, J. Courjon, V. Giordanengo, V. Vieira and 8 other author(s). International Journal of Antimicrobial Agents, 56 (1): 105949 (2020)

BibSonomy

Disambiguation of "Scola, Bernard La"

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects

Please choose a person to relate this publication to

Egmont Scola

Egmont Scola

Roland Scola

Alexander Scola

Wolfgang Scola

Other publications of authors with the same name

Disambiguation

BibSonomy

Disambiguation of "Scola, Bernard La"

copydeleteadd this publication to your clipboardcommunity posthistory of this postURLDOIBibTeXEndNoteAPAChicagoDIN 1505HarvardMSOffice XML SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects

Please choose a person to relate this publication to

Egmont Scola

Egmont Scola

Roland Scola

Alexander Scola

Wolfgang Scola

Other publications of authors with the same name

Disambiguation

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects